These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32471980)

  • 1. The interaction of interleukin-8 and PTEN inactivation promotes the malignant progression of head and neck squamous cell carcinoma via the STAT3 pathway.
    Xu Q; Ma H; Chang H; Feng Z; Zhang C; Yang X
    Cell Death Dis; 2020 May; 11(5):405. PubMed ID: 32471980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-8 promotes HNSCC progression on CXCR1/2-meidated NOD1/RIP2 signaling pathway.
    Chan LP; Wang LF; Chiang FY; Lee KW; Kuo PL; Liang CH
    Oncotarget; 2016 Sep; 7(38):61820-61831. PubMed ID: 27557518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway.
    Yadav A; Kumar B; Datta J; Teknos TN; Kumar P
    Mol Cancer Res; 2011 Dec; 9(12):1658-67. PubMed ID: 21976712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis.
    Zhao M; Hu X; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Zhang L; Jin R; Zhou X
    Int J Oncol; 2019 Nov; 55(5):1165-1175. PubMed ID: 31545422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (-)-Epigallocatechin gallate induces Fas/CD95-mediated apoptosis through inhibiting constitutive and IL-6-induced JAK/STAT3 signaling in head and neck squamous cell carcinoma cells.
    Lin HY; Hou SC; Chen SC; Kao MC; Yu CC; Funayama S; Ho CT; Way TD
    J Agric Food Chem; 2012 Mar; 60(10):2480-9. PubMed ID: 22313388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma.
    Li J; Shi C; Zhou R; Han Y; Xu S; Ma H; Zhang Z
    Cancer Sci; 2020 Sep; 111(9):3222-3235. PubMed ID: 32589311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slug is a novel molecular target for head and neck squamous cell carcinoma stem-like cells.
    Moon JH; Lee SH; Koo BS; Kim JM; Huang S; Cho JH; Eun YG; Shin HA; Lim YC
    Oral Oncol; 2020 Dec; 111():104948. PubMed ID: 32771963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
    Li B; Zhu J; Meng L
    Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
    Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
    Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD147 promotes progression of head and neck squamous cell carcinoma via NF-kappa B signaling.
    Yu B; Zhang Y; Wu K; Wang L; Jiang Y; Chen W; Yan M
    J Cell Mol Med; 2019 Feb; 23(2):954-966. PubMed ID: 30421493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LASP1 promotes proliferation, metastasis, invasion in head and neck squamous cell carcinoma and through direct interaction with HSPA1A.
    Chen Q; Wu K; Qin X; Yu Y; Wang X; Wei K
    J Cell Mol Med; 2020 Jan; 24(2):1626-1639. PubMed ID: 31793711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPRT promotes proliferation and metastasis in head and neck squamous cell carcinoma through direct interaction with STAT3.
    Wang L; Wang Y; Han N; Wang X; Ruan M
    Exp Cell Res; 2021 Feb; 399(1):112424. PubMed ID: 33340493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
    St John MA
    Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
    Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS
    Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KLF4, Slug and EMT in Head and Neck Squamous Cell Carcinoma.
    Ingruber J; Savic D; Steinbichler TB; Sprung S; Fleischer F; Glueckert R; Schweigl G; Skvortsova II; Riechelmann H; Dudás J
    Cells; 2021 Mar; 10(3):. PubMed ID: 33802627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis.
    Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS
    Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Genes Encoding Cell Motility Proteins during Progression of Head and Neck Squamous Cell Carcinoma.
    Kakurina GV; Kondakova IV; Spirina LV; Kolegova ES; Shashova EE; Cheremisina OV; Novikov VA; Choinzonov EL
    Bull Exp Biol Med; 2018 Dec; 166(2):250-252. PubMed ID: 30488206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RhoC regulates cancer stem cells in head and neck squamous cell carcinoma by overexpressing IL-6 and phosphorylation of STAT3.
    Islam M; Sharma S; Teknos TN
    PLoS One; 2014; 9(2):e88527. PubMed ID: 24533098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3/HOTAIR Signaling Axis Regulates HNSCC Growth in an EZH2-dependent Manner.
    Sun S; Wu Y; Guo W; Yu F; Kong L; Ren Y; Wang Y; Yao X; Jing C; Zhang C; Liu M; Zhang Y; Zhao M; Li Z; Wu C; Qiao Y; Yang J; Wang X; Zhang L; Li M; Zhou X
    Clin Cancer Res; 2018 Jun; 24(11):2665-2677. PubMed ID: 29540490
    [No Abstract]   [Full Text] [Related]  

  • 20. Phosphorylation of STAT3 in head and neck cancer requires p38 MAPKinase, whereas phosphorylation of STAT1 occurs via a different signaling pathway.
    Riebe C; Pries R; Schroeder KN; Wollenberg B
    Anticancer Res; 2011 Nov; 31(11):3819-25. PubMed ID: 22110204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.